IFNA1 and Cirrhosis: In patients with cirrhosis, HDV infection was not associated with the long-term outcome (p = 0.61; CI 0.69–1.89), whereas therapy with IFN and therapy with NA was univariably associated with the clinical outcome (p < 0.01; CI 0.17–0.58), (p = 0.02; CI 1.11–2.68) (Table 2b).